It has been shown that CBX5 rescue or miR-589–5p silencing can reverse the suppressive effects of silenced LOXL1-AS1 on the malignant phenotype of RCC (111) (Figure 6). This evidence concerns the gene LOXL1 and renal cell carcinoma.